FERAHEME (also known as Ferumoxytol)
Mechanism:
Feraheme is an iron replacement product.
Indications:
Treatment of iron deficiency anemia in adult patients with chronic kidney disease.
Contraindications:
Patients with active infection should not be started on Feraheme.
Administration:
Feraheme is administered as an infusion and usually repeated 3-8 days later after the first infusion. Frequency of repeat administration is based on patient’s response.